Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
Yingmei Luo, Ze Chen, Mingjian Sun, et al.
Biomaterials (2021) Vol. 281, pp. 121341-121341
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 85
Magnetic–Acoustic Sequentially Actuated CAR T Cell Microrobots for Precision Navigation and In Situ Antitumor Immunoactivation
Xiaofan Tang, Ye Yang, Mingbin Zheng, et al.
Advanced Materials (2023) Vol. 35, Iss. 18
Closed Access | Times Cited: 47
Chemically engineering cells for precision medicine
Yixin Wang, Zhaoting Li, Fanyi Mo, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 1068-1102
Closed Access | Times Cited: 41
Albumin Nanoparticle-Based Drug Delivery Systems
Na Qu, Ke Song, Yating Ji, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6945-6980
Open Access | Times Cited: 17
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry
Wenzhe Yi, Ping Xiao, Xiaochen Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 68
Spinal cord tissue engineering via covalent interaction between biomaterials and cells
Weiyuan Liu, Xu Bai, Shuaijing Zhao, et al.
Science Advances (2023) Vol. 9, Iss. 6
Open Access | Times Cited: 39
In Situ Activated NK Cell as Bio‐Orthogonal Targeted Live‐Cell Nanocarrier Augmented Solid Tumor Immunotherapy
Dandan Meng, Hong Pan, Wei He, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 29
Closed Access | Times Cited: 38
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy
David Andreu-Sanz, Sebastian Kobold
Cancers (2023) Vol. 15, Iss. 6, pp. 1650-1650
Open Access | Times Cited: 29
Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective
Changyong Li, Da-Gui Zhang, Yu-Jing Pan, et al.
Polymers (2023) Vol. 15, Iss. 16, pp. 3354-3354
Open Access | Times Cited: 29
Optimizing the manufacturing and antitumour response of CAR T therapy
Yutong Liu, Adam S. Sperling, Eric L. Smith, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 271-285
Closed Access | Times Cited: 25
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 14
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Jiawen Huang, Xiaobing Huang, Juan Huang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Engineering cytokines for cancer immunotherapy: a systematic review
Yong Fu, Renhong Tang, Xiaofeng Zhao
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Xinping Cao, Xin Jin, Xiaomei Zhang, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 3, pp. 184-211
Open Access | Times Cited: 16
Recent Advances in Nanomodulators for Augmenting Cancer Immunotherapy in Cold Tumors: Insights from Drug Delivery to Drug‐Free Strategies
Lingxiao Zhang, Chaojie Zhu, Jing Zhao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 18
Open Access | Times Cited: 7
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Nanodrug Delivery Systems in Antitumor Immunotherapy
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7
Nanomaterials Boost CAR‐T Therapy for Solid Tumors
Jun Long, Yian Wang, Xianjie Jiang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 7
Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects
Yuankui Zhu, Ke Wang, Linghe Yue, et al.
Pharmacological Research (2024) Vol. 203, pp. 107186-107186
Open Access | Times Cited: 7
Engineering cells for therapy and diagnosis
Zhaoting Li, Yixin Wang, Zhen Gu, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 770-784
Closed Access | Times Cited: 7
Nanodrugs Targeting T Cells in Tumor Therapy
Maximilian Haist, Volker Mailänder, Matthias Bros
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Cell‐Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy
Xiaoyuan Fan, Kaiyuan Wang, Lu Qi, et al.
Small (2022) Vol. 19, Iss. 4
Closed Access | Times Cited: 23
Nano-immunotherapy for lung cancer
Yuting Lu, Tangye Zeng, Huamiao Zhang, et al.
Deleted Journal (2023) Vol. 2, Iss. 1, pp. e9130018-e9130018
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top